TWO SIGMA INVESTMENTS, LP - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 94 filers reported holding ANTARES PHARMA INC in Q3 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$2,708,000
+62.2%
660,601
+41.3%
0.01%
+100.0%
Q4 2021$1,670,000
-58.1%
467,655
-57.3%
0.00%
-55.6%
Q3 2021$3,984,000
-31.3%
1,094,510
-17.7%
0.01%
-30.8%
Q2 2021$5,798,000
+1.9%
1,329,845
-3.9%
0.01%
-13.3%
Q1 2021$5,689,000
+32.4%
1,384,127
+28.5%
0.02%
+25.0%
Q4 2020$4,298,000
+40.3%
1,077,153
-5.1%
0.01%
+9.1%
Q3 2020$3,064,000
-12.8%
1,134,976
-11.1%
0.01%
-35.3%
Q2 2020$3,512,000
-1.3%
1,277,070
-15.3%
0.02%
-41.4%
Q1 2020$3,560,000
-61.9%
1,508,476
-24.0%
0.03%
+3.6%
Q4 2019$9,334,000
+922.3%
1,986,035
+627.4%
0.03%
+833.3%
Q3 2019$913,000
-46.4%
273,046
-47.3%
0.00%
-50.0%
Q2 2019$1,704,000
-18.7%
518,013
-25.1%
0.01%
-14.3%
Q1 2019$2,095,000
+25.1%
691,293
+12.3%
0.01%0.0%
Q4 2018$1,674,000
+89.8%
615,462
+134.3%
0.01%
+250.0%
Q3 2018$882,000
-40.3%
262,632
-42.4%
0.00%
-60.0%
Q3 2017$1,477,000
+322.0%
455,720
+319.3%
0.01%
+400.0%
Q2 2017$350,000
+900.0%
108,685
+173.8%
0.00%
Q1 2016$35,000
-50.7%
39,692
-32.1%
0.00%
Q4 2015$71,000
-64.7%
58,477
+17.7%
0.00%
-100.0%
Q3 2013$201,00049,6680.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,055,0004.58%
Centric Wealth Management 3,337,449$13,717,0003.92%
Sargent Investment Group, LLC 3,599,580$14,794,0003.90%
Rubric Capital Management LP 8,722,647$35,850,0002.09%
PERKINS CAPITAL MANAGEMENT INC 542,283$2,229,0001.29%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$7,809,0001.17%
Venator Capital Management Ltd. 550,000$2,624,0000.89%
LEVEL FOUR FINANCIAL, LLC 120,000$493,0000.23%
ALGERT GLOBAL LLC 147,616$607,0000.19%
Brown Advisory Securities, LLC 275,000$1,130,0000.19%
View complete list of ANTARES PHARMA INC shareholders